It is with deep sorrow that the Belgian Society of Cardiology learns of the Ukrainian crisis in the heart of Europe. The BSC has remained committed to scientific and educational co-operation both within Belgium and to the wider Cardiology community, with the aim to reduce the burden of cardiovascular disease. The BSC condemns the unwarranted...
News
Post
Call for Participation in ESC Guidelines Task Forces
The ESC has opened a first time invitation to an “open call”, to broaden the pool of contributors and give topic experts the opportunity to volunteer to be part of the 2024 ESC Guideline Task Forces. In 2024, the ESC will release four updated Clinical Practice Guidelines, which will cover the topics of: atrial fibrillation,...
Post
Diabetes and Heart campaign
In collaboration with the Belgian Heart Ligue, the Belgian Heart Foundation created a campaign on the relation between Diabetes and Cardiovascular diseases. The aim is to raise awareness to heart or diabetes patients, about the risks of developing an additional condition. Some statistics: 1 adult in 10 in Belgium has diabetes (for 90 to 95%...
Post
In memoriam – Prof Olivier Van Caenegem
The Belgian Society of Cardiology mourns the sudden and unexpected passing of Prof. Olivier Van Caenegem on August 2nd. Prof. Van Caenegem graduated from the UCLouvain Medical School in 1993 and specialized in cardiology and in intensive care. He worked since 2001 in the Cardiovascular Intensive Care Unit in the Cliniques Universitaires St. Luc and...
Post
BHF Call for Research
The jury of the 2021 BHF grants review would like to thank every one that took part. The results will be available shortly. In the second quarter of 2022 a new call for projects will be opened and the information will be available from this website.
Post
Marevan (warfarin)
Marevan (warfarin) – 60 tablet boxes are not available at the moment (communication of the FAGG/AFMPS). In order to continue treatment in patients with a clear indication for the use of classic Vit K antagonists, either warfarin can be acquired through the pharmacist in neighbouring countries or exchanged for another component (see the 2019 proposed...
Post
Covid-19 Latest News medication related
In the newspaper MEUSE of March 25, 2020, it was mentioned that certain drugs to fight “blood pressure problems” would increase the risk of contracting COVID-19. As a cardiologist, I would like to add some nuances to this subject. The article focuses primarily on ACE inhibitors and ARBs that are very effective in reducing the...
Post
COVID-19 Patient information
The ESC Patient Forum has received many questions about the Corona Virus (COVID-19). These questions and answers intend to pool together useful recommendations from international authorities and medical societies that are available at this point in time (publication date/last updated: March 26th, 2020). Please click on the following link for the detailed publication: ESC Heart patient...
Post
STEMI and COVID in Belgium
Impact of COVID-19-related public containment measures on the ST elevation myocardial infarction epidemic in Belgium: a nationwide, serial, cross-sectional study. For the article published in ACTA Cardiologa please click: STEMI and COVID in Belgium